technolog
innov
novel
applic
greatli
advanc
field
protein
microarray
past
two
year
differ
type
protein
microarray
use
serum
profil
protein
abund
determin
identif
protein
bind
dna
small
compound
howev
consider
develop
still
requir
ensur
common
qualiti
standard
establish
larg
content
repertoir
summar
applic
avail
date
discuss
recent
technolog
achiev
effort
standard
global
concept
array
technolog
simultan
analysi
thousand
molecul
specif
properti
investig
end
protein
array
initi
introduc
screen
cdna
librari
clone
express
recombin
protein
escherichia
coli
purpos
thousand
differ
express
clone
array
bacteria
larg
protein
bind
membran
induct
cell
lysi
presenc
recombin
protein
array
correl
individu
clone
subsequ
miniatur
led
protein
microarray
typic
construct
spot
protein
sampl
onto
microscop
slide
current
protein
microarray
come
varieti
format
includ
standard
protein
microarray
pma
consist
purifi
recombin
protein
antibodi
microarray
ama
revers
protein
microarray
rpma
gener
whole
fraction
cell
lysat
depict
figur
although
applic
pma
differ
wide
gener
concept
detect
interact
partner
appli
put
bind
partner
incub
array
protein
bind
detect
use
label
either
coval
bound
put
interact
partner
figur
secondari
antibodi
novel
labelfre
method
detail
addit
principl
delin
array
result
pma
type
signal
label
array
spot
correl
interact
known
spot
content
accord
posit
array
discuss
applic
technolog
advanc
detect
system
develop
past
two
year
moreov
effort
toward
standard
protein
microarray
experiment
review
earliest
applic
pma
figur
left
determin
antibodi
specif
use
array
denatur
recombin
protein
sinc
michaud
et
al
extend
approach
proteomewid
yeast
pma
compar
specif
monoclon
polyclon
antibodi
addit
pma
recombin
protein
use
identifi
potenti
diagnost
marker
exampl
pma
human
recombin
protein
use
determin
humor
immun
respons
associ
differ
diseas
autoimmun
diseas
discuss
robinson
issu
also
pma
present
microbi
viral
protein
introduc
identif
new
potenti
diagnost
marker
vaccin
candid
exampl
kreutzberg
cowork
analyz
sera
mening
patient
pma
present
select
recombin
neisseria
meningitid
protein
patient
serum
antibodi
recogn
protein
half
patient
test
antibodi
opav
protein
make
potenti
diagnost
marker
anoth
bacteri
pma
contain
yersinia
pesti
protein
use
profil
antibodi
respons
sera
rabbit
immun
previous
live
plagu
vaccin
total
protein
trigger
immun
reaction
eleven
identifi
potenti
candid
new
diagnost
marker
vaccin
compon
viral
pma
use
qiu
et
al
investig
sever
acut
respiratori
syndrom
sar
screen
identifi
uniqu
immunogen
protein
promis
vaccin
candid
well
screen
antibodi
pma
use
identif
enzym
substrat
instanc
pma
present
nonredund
set
approxim
denatur
arabidopsi
thaliana
protein
address
differ
mitogen
activ
protein
map
kinas
besid
known
suspect
target
novel
unpredict
kinas
substrat
transcript
factor
histon
kinas
ribosom
protein
identifi
recent
exampl
proteinprotein
interact
screen
demonstr
kawahasi
colleagu
use
three
select
pair
model
protein
known
interact
protein
synthes
use
wheatgermbas
cellfre
protein
translat
system
shown
suitabl
highthroughput
protein
express
supplement
translat
system
yield
fluorescencelabel
protein
could
directli
use
arraybas
interact
screen
author
demonstr
previous
incorpor
differ
fluoresc
dye
cterminu
protein
provid
basi
arraybas
interact
screen
multipl
put
interact
partner
parallel
accordingli
expect
rapid
applic
innov
approach
larger
scale
anoth
instanc
letart
et
al
studi
interact
human
leukocyt
membran
protein
cell
surfac
receptor
use
panel
pointmut
receptor
antigen
epitop
two
monoclon
antibodi
map
subsequ
low
affin
interact
bind
receptor
demonstr
one
first
studi
detect
smallmoleculedepend
proteinprotein
interact
conduct
sasakura
cowork
success
demonstr
strictli
campdepend
interact
escherichia
coli
phosphodiesteras
ec
do
isol
pa
domain
enzym
meanwhil
pma
also
use
analyz
proteindna
interact
regul
coordin
express
gene
use
bacteri
model
system
specif
detect
proteindna
interact
protein
microarray
demonstr
dynam
concentr
rang
four
order
magnitud
find
verifi
electromobl
shift
assay
probe
proteomewid
yeast
pma
fluoresc
label
genom
dna
identifi
dna
bind
protein
result
excel
agreement
chromatin
immunoprecipit
experi
half
identifi
protein
known
expect
dna
binder
wherea
remain
half
novel
dna
interactor
followup
experi
reveal
metabol
enzym
involv
ornithin
biosynthesi
precursor
arginin
associ
specif
mitochondri
nuclear
loci
vivo
appli
yeast
proteomewid
pma
protein
target
two
small
molecul
known
influenc
target
rapamycin
tor
pathway
determin
molecul
multipl
protein
interact
partner
found
futur
similar
experi
help
deciph
mechan
smallmoleculederiv
pharmaceut
use
modern
medicin
overcom
ondemand
avail
purifi
protein
major
bottleneck
pma
ramachandran
et
al
print
cdna
direct
vicin
captur
antibodi
gstfusion
tag
ad
cellfre
express
system
gstfusion
protein
gener
directli
microarray
immedi
retain
adjac
antigst
antibodi
result
microarray
qualiti
control
verifi
content
protein
spot
proteinspecif
antibodi
subsequ
pairwis
interact
among
human
dna
replic
protein
demonstr
antibodi
microarray
ama
figur
middl
great
potenti
mani
field
broad
commerci
diagnost
assess
environment
pollut
qualiti
control
exampl
food
industri
simpli
comprehens
research
tool
use
ultim
hold
promis
complement
rna
express
profil
stabl
interact
dynam
process
protein
level
howev
despit
grow
number
success
applic
ama
use
current
limit
specif
investig
defin
rel
small
set
antibodi
partial
due
limit
avail
wellcharacter
antibodi
well
technic
challeng
report
elsewher
recent
success
applic
ama
work
koga
colleagu
studi
tissuespecif
express
protein
use
antibodi
gener
mous
kiaa
kazusa
dna
research
institut
aa
refer
charact
protein
protein
abund
assess
labelfre
realtim
signal
detect
use
surfac
plasmon
reson
spr
technolog
biosensor
flexchip
tm
biacor
ab
uppsala
sweden
amaderiv
protein
abund
compar
mrna
abund
posit
correl
found
gene
product
neg
correl
determin
attribut
pronounc
differ
tissuespecif
rna
protein
stabil
date
labelfre
detect
pma
wide
appli
current
sandwich
immunoassay
reliabl
microarraybas
quantif
system
protein
content
use
howev
detect
analyt
requir
two
specif
antibodi
bind
differ
region
analyt
third
detect
antibodi
commonli
appli
avoid
potenti
loss
specif
sensit
detect
antibodi
result
label
reaction
use
third
antibodi
howev
result
increas
unspecif
signal
due
recognit
conserv
region
captur
detect
antibodi
overcom
obstacl
song
et
al
remov
fc
part
tumormark
captur
antibodi
pepsin
digest
array
antigenbind
fragment
f
ab
six
differ
tumor
marker
subsequ
calibr
curv
deriv
use
pure
serum
dilut
tumor
marker
final
author
demonstr
readout
obtain
f
ab
microarray
correl
well
r
obtain
standard
immunoassay
human
serum
sampl
third
exampl
innov
use
ama
shown
ko
colleagu
appli
live
rat
neural
stem
cell
nsc
onto
microarray
surfacemarkerspecif
antibodi
presenc
marker
heterogen
neurosphereform
cell
popul
investig
addit
situ
cultiv
subsequ
immunostain
arraybound
cell
allow
assess
prolifer
capabl
nsc
contrast
type
protein
microarray
describ
rpma
figur
right
base
regular
arrang
complex
nonpurifi
sometim
fraction
protein
mixtur
usual
deriv
cell
tissu
lysat
provid
access
posttransl
modifi
protein
far
access
highthroughput
method
array
lysat
differ
cell
line
andor
biopsi
support
rel
abund
differ
protein
mixtur
determin
provid
highli
specif
detect
reagent
avail
recent
applic
focus
analysi
cancer
specimen
use
highli
specif
antibodi
differ
partli
posttransl
modifi
member
signal
cascad
major
advantag
rpma
requir
minut
amount
ml
ml
ngml
model
protein
protein
extract
gener
ten
microarray
contrast
gel
electrophoret
applic
analyz
highli
autom
fashion
addit
multipl
replica
dilut
seri
includ
microarray
increas
robust
protein
quantif
wide
rang
concentr
good
exampl
rpma
fraction
sampl
present
nam
et
al
array
protein
fraction
lovo
colon
cancer
cell
line
one
protein
fraction
gave
posit
signal
sera
deriv
colon
cancer
patient
control
sera
subsequ
mass
spectrometr
analysi
fraction
identifi
cterminu
ubiquitinyl
hydrolas
target
furthermor
janzi
et
al
spot
total
sera
patient
one
microarray
quantit
screen
iga
defici
ultim
aim
earli
detect
immunodefici
newborn
author
abl
detect
less
mg
iga
per
ml
serum
chan
colleagu
appli
wholecel
lysat
rpma
jurkat
tcell
monitor
dynam
sitespecif
phosphoryl
signal
molecul
analys
signal
cascad
author
determin
dynam
rang
approach
approxim
four
order
magnitud
detect
limit
one
protein
lysat
protein
subsequ
kinet
phosphoryl
phospholipas
c
plc
jurkat
cell
activ
receptor
analyz
take
total
content
phospholipas
c
consider
author
determin
rel
phosphoryl
level
rapidli
upregul
within
first
min
stimul
crosslink
upregul
diminish
baselin
min
stimul
result
less
pronounc
prolong
phosphoryl
addit
downstream
signal
pathway
delin
varieti
novel
method
increas
sensit
develop
detect
low
abund
protein
report
sensit
summar
tabl
exampl
angenendt
colleagu
develop
subnanolit
enzymat
assay
system
standard
microarray
allow
detect
enzymat
activ
molecul
individu
spot
recent
ama
applic
signal
detect
often
carri
direct
multicolor
label
rollingcircl
amplif
rca
system
requir
direct
conjug
protein
analyz
label
biotin
digoxigenin
antibodi
conjug
primer
detect
label
hybrid
circular
dna
molecul
primer
extend
endlessli
polymeras
subsequ
specif
oligonucleotid
complementari
elong
dna
fragment
hybrid
produc
specif
signal
amplif
major
advantag
rca
superior
sensit
reproduc
increas
signal
intens
report
gao
et
al
success
appli
rca
detect
ama
consist
distinct
antibodi
specif
serum
protein
compar
protein
express
profil
lung
cancer
patient
equal
number
healthi
chronic
obstruct
pulmonari
diseas
patient
sever
protein
identifi
abund
lung
cancer
detect
sensit
pma
increas
introduct
encapsul
semiconductor
nanocryst
commonli
refer
quantum
dot
qd
novel
class
fluoresc
probe
avail
mani
differ
wavelength
high
extinct
coeffici
quantum
yield
qd
expect
inert
environment
factor
eg
ozon
deterior
fluoresc
dye
great
potenti
appli
multiplex
highli
parallel
analysi
mani
differ
sampl
singl
microarray
multiplex
strategi
review
recent
mani
differ
surfac
gener
pma
describ
discuss
extens
besid
tether
protein
surfac
adhes
recent
advanc
protein
microarray
hultschig
et
al
tabl
applic
detect
limit
monitor
chang
ptm
upon
initi
cellular
process
serum
profil
identif
serum
diseas
marker
mg
igaml
serum
protein
lysat
protein
coval
attach
nonori
fashion
recent
develop
direct
immobil
protein
emerg
effort
address
challeng
loss
enzymat
activ
due
unfavor
orient
immobil
enzym
overcom
obstacl
ofir
et
al
attach
protein
via
cellulos
bind
protein
celluloseco
microarray
relat
approach
link
protein
dna
coat
microarray
via
dna
bind
domain
oligonucleotid
duplex
addit
direct
immobil
antibodi
slayersselfassembl
structur
resembl
bacteri
cell
wall
use
gener
recrystal
bdomain
protein
analogu
domain
like
synthet
zdomain
support
precoat
secondari
cell
wall
polym
domain
captur
fc
part
immunoglobulin
direct
fashion
despit
develop
mani
differ
surfac
last
five
year
notabl
systemat
investig
conduct
yet
univers
surfac
ideal
applic
could
identifi
henc
care
comparison
data
deriv
form
differ
surfac
crosstechnolog
platform
suitabl
standard
still
issu
microarray
experi
multitud
differ
factor
crucial
qualiti
reliabl
final
readout
experi
respect
limit
level
consist
differ
commerci
dna
microarray
platform
express
profil
respect
diverg
group
protein
microarray
individu
standard
type
pma
applic
reason
standard
contain
detail
inform
aim
array
base
experi
experiment
design
content
design
array
well
qualiti
control
content
control
includ
array
addit
inform
origin
isol
label
sampl
incub
array
procedur
paramet
incub
subsequ
downstream
process
imag
acquisit
quantif
need
ideal
extend
minimum
amount
inform
similar
miam
standard
propos
dna
microarray
establish
area
antibodi
microarray
normal
procedur
compar
abund
analysi
alreadi
adapt
cdna
microarray
field
despit
signific
challeng
associ
task
work
haab
et
al
show
appli
common
standard
yield
equival
result
differ
laboratori
past
two
year
seen
impress
progress
pma
technolog
protein
antibodi
microarray
technolog
taken
import
step
toward
diagnost
biomark
discoveri
whole
proteom
microarray
enabl
unbias
experi
reveal
unforeseen
biolog
activ
unknown
also
wellcharacter
protein
addit
proteomewid
pma
identifi
interact
partner
miss
largescal
yeasttwohybrid
screen
field
rpma
open
possibl
gain
indepth
insight
cellular
process
provid
access
posttransl
modifi
protein
futur
standard
effort
indispens
compar
pma
result
obtain
independ
laboratori
first
paper
detect
proteinprotein
interact
use
vitro
synthes
protein
array
put
interact
partner
fluoresc
label
vitro
synthesi
